Search Results - Colleen Mockbee
- Showing 1 - 2 results of 2
-
1
Targeting Phosphatidylserine in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas: A Phase 2 Trial of Bavituximab Plus Pembrolizumab with Biomarker-Correlated Outcomes by Panagiotis Ntellas, Haeseong Park, Kerry Culm, Jeeyun Lee, Hagop Youssoufian, Colleen Mockbee, Mark Uhlik, Laura Benjamin, Ian Chau
Published in Current Oncology (2026-05-01)Get full text
Article -
2
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial by David Hsiehchen, Muhammad S. Beg, Radhika Kainthla, Jay Lohrey, Syed M. Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, Ellen Siglinsky, Anil K. Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura Benjamin, Rolf A. Brekken, Chul Ahn, Amit G. Singal, Hao Zhu, Yujin Hoshida, Adam C. Yopp
Published in Nature Communications (2024-03-01)Get full text
Article
